Correction: 2017 ACC Expert Consensus Decision Pathway on the Management of Mitral Regurgitation: A Report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways (Journal of the American College of Cardiology (2017) 70(19) (2421–2449)(S0735109717396778)(10.1016/j.jacc.2017.09.019));2017 ACC Expert Consensus Decision Pathway on the Management of Mitral Regurgitation: A Report of the American College of Cardiology Task Force on Expert Consensus Decision Pathways

Journal of the American College of Cardiology

Volumn 70, Issue 19, 2017, Pages 2421-2449

  O'Gara, Patrick T ^a   Grayburn, Paul A ^a   Badhwar, Vinay ^a   Afonso, Luis C ^a   Carroll, John D ^a   Elmariah, Sammy ^a   Kithcart, Aaron P ^a   Nishimura, Rick A ^a   Ryan, Thomas J ^a   Schwartz, Allan ^a   Stevenson, Lynne Warner ^a  

^a NONE

Author keywords

echocardiography; Expert Consensus Decision Pathway; mitral regurgitation; mitral valve; transcatheter; valve repair; valve surgery

Indexed keywords

ARTICLE; COLOR DOPPLER FLOWMETRY; CONSENSUS; DISEASE SEVERITY; DYNAMICS; ECHOCARDIOGRAPHY; EVALUATION STUDY; FEASIBILITY STUDY; FOLLOW UP; HEALTH CARE ACCESS; HEART CATHETERIZATION; HEART HEMODYNAMICS; HUMAN; INTERPERSONAL COMMUNICATION; MEDICAL HISTORY; MITRAL VALVE REGURGITATION; MITRAL VALVE REPAIR; MITRAL VALVE SURGERY; PHYSICAL EXAMINATION; PRACTICE GUIDELINE; PRIORITY JOURNAL; PROGNOSIS; QUANTITATIVE ANALYSIS; SHARED DECISION MAKING; SURGICAL RISK; TRANSCATHETER EDGE TO EDGE LEAFLET COAPTATION; TREATMENT INDICATION; ADVISORY COMMITTEE; CARDIOLOGY; CLINICAL DECISION MAKING; DISEASE MANAGEMENT; MITRAL VALVE INSUFFICIENCY; PROCEDURES; RESEARCH; STANDARDS; UNITED STATES;

ADVISORY COMMITTEES; CARDIOLOGY; CLINICAL DECISION-MAKING; CONSENSUS; DISEASE MANAGEMENT; HUMANS; MITRAL VALVE INSUFFICIENCY; RESEARCH REPORT; UNITED STATES;

EID: 85031773027     PISSN: 07351097     EISSN: 15583597     Source Type: Journal    
DOI: 10.1016/j.jacc.2017.11.026     Document Type: Erratum

References (97)

1. Nishimura, R.A., Otto, C.M., Bonow, R.O., et al. 2014 AHA/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines. J Am Coll Cardiol 63 (2014), 2438–2488.
2. Nishimura, R.A., Otto, C.M., Bonow, R.O., et al. 2017 AHA/ACC focused update of the 2014 AHA/ACC Guideline for the Management of Patients With Valvular Heart Disease: a report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines. J Am Coll Cardiol, 2017 Mar 15 [E-pub ahead of print].
3. Zoghbi, W.A., Adams, D., Bonow, R.O., et al. Recommendations for noninvasive evaluation of native valvular regurgitation: a report from the American Society of Echocardiography Developed in Collaboration with the Society for Cardiovascular Magnetic Resonance. J Am Soc Echocardiogr 30 (2017), 303–371.
4. O'Gara, P.T., Calhoon, J.H., Moon, M.R., et al. Transcatheter therapies for mitral regurgitation: a professional society overview from the American College of Cardiology, the American Association for Thoracic Surgery, Society for Cardiovascular Angiography and Interventions Foundation, and the Society of Thoracic Surgeons. J Am Coll Cardiol 63 (2014), 840–852.
5. Nkomo, V.T., Gardin, J.M., Skelton, T.N., et al. Burden of valvular heart diseases: a population-based study. Lancet 368 (2006), 1005–1011.
6. Wang, A., Grayburn, P., Foster, J.A., et al. Practice gaps in the care of mitral valve regurgitation: insights from the American College of Cardiology mitral regurgitation gap analysis and advisory panel. Am Heart J 172 (2016), 70–79.
7. Tribouilloy, C., Rusinaru, D., Grigioni, F., et al. Long-term mortality associated with left ventricular dysfunction in mitral regurgitation due to flail leaflets: a multicenter analysis. Circ Cardiovasc Imaging 7 (2014), 363–370.
8. Grodin, J.L., Hammadah, M., Fan, Y., et al. Prognostic value of estimating functional capacity with the use of the duke activity status index in stable patients with chronic heart failure. J Card Fail 21 (2015), 44–50.
9. Grayburn, P.A., Appleton, C.P., DeMaria, A.N., et al. Echocardiographic predictors of morbidity and mortality in patients with advanced heart failure: the Beta-blocker Evaluation of Survival Trial (BEST). J Am Coll Cardiol 45 (2005), 1064–1071.
10. Society of Thoracic Surgeons, American College of Cardiology. STS/ACC TVT Registry v2.0 for transcatheter aortic valve replacement procedures. Available at: http://www.ncdr.com/WebNCDR/docs/default-source/tvt-public-page-documents/tvt-registry_2_0_tavr_data-collection-form.pdf?sfvrsn=2. Accessed February 26, 2017.
11. Health Measures. Patient-Reported Outcomes Measurement Information System. Available at: http://www.healthmeasures.net/explore-measurement-systems/promis. Accessed February 26, 2017.
12. Leung, D.Y., Griffin, B.P., Stewart, W.J., et al. Left ventricular function after valve repair for chronic mitral regurgitation: predictive value of preoperative assessment of contractile reserve by exercise echocardiography. J Am Coll Cardiol 28 (1996), 1198–1205.
13. Naji, P., Griffin, B.P., Asfahan, F., et al. Predictors of long-term outcomes in patients with significant myxomatous mitral regurgitation undergoing exercise echocardiography. Circulation 129 (2014), 1310–1319.
14. Lancellotti, P., Troisfontaines, P., Toussaint, A.C., et al. Prognostic importance of exercise-induced changes in mitral regurgitation in patients with chronic ischemic left ventricular dysfunction. Circulation 108 (2003), 1713–1717.
15. Magne, J., Lancellotti, P., Pierard, L.A., Exercise pulmonary hypertension in asymptomatic degenerative mitral regurgitation. Circulation 122 (2010), 33–41.
16. ATS Committee on Proficiency Standards for Clinical Pulmonary Function. ATS statement. American Thoracic Society guidelines for the six-minute walk test. Am J Respir Crit Care Med 166 (2002), 111–117.
17. Fang, J.C., O'Gara, P.T., The history and physical examination: an evidence-based approach. Mann, D., Zipes, D., Libby, P., Bonow, R., (eds.) Braunwald's Heart Disease: A Textbook of Cardiovascular Medicine, 10th Edition, 2015, Elsevier/Saunders, Philadelphia, Pa, 95–113.
18. Hickey, M.S., Smith, L.R., Muhlbaier, L.H., et al. Current prognosis of ischemic mitral regurgitation. Implications for future management. Circulation 78 (1988), I51–I59.
19. Grigioni, F., Enriquez-Sarano, M., Zehr, K.J., et al. Ischemic mitral regurgitation: long-term outcome and prognostic implications with quantitative Doppler assessment. Circulation 103 (2001), 1759–1764.
20. Trichon, B.H., Felker, G.M., Shaw, L.K., et al. Relation of frequency and severity of mitral regurgitation to survival among patients with left ventricular systolic dysfunction and heart failure. Am J Cardiol 91 (2003), 538–543.
21. Rossi, A., Dini, F.L., Faggiano, P., et al. Independent prognostic value of functional mitral regurgitation in patients with heart failure. A quantitative analysis of 1256 patients with ischaemic and non-ischaemic dilated cardiomyopathy. Heart 97 (2011), 1675–1680.
22. Deja, M.A., Grayburn, P.A., Sun, B., et al. Influence of mitral regurgitation repair on survival in the surgical treatment for ischemic heart failure trial. Circulation 125 (2012), 2639–2648.
23. Patel, J.B., Borgeson, D.D., Barnes, M.E., et al. Mitral regurgitation in patients with advanced systolic heart failure. J Card Fail 10 (2004), 285–291.
24. Cioffi, G., Tarantini, L., De Feo, S., et al. Functional mitral regurgitation predicts 1-year mortality in elderly patients with systolic chronic heart failure. Eur J Heart Fail 7 (2005), 1112–1117.
25. Ben Zekry, S., Nagueh, S.F., Little, S.H., et al. Comparative accuracy of two- and three-dimensional transthoracic and transesophageal echocardiography in identifying mitral valve pathology in patients undergoing mitral valve repair: initial observations. J Am Soc Echocardiogr 24 (2011), 1079–1085.
26. Silbiger, J.J., Novel pathogenetic mechanisms and structural adaptations in ischemic mitral regurgitation. J Am Soc Echocardiogr 26 (2013), 1107–1117.
27. Chikwe, J., Adams, D.H., Su, K.N., et al. Can three-dimensional echocardiography accurately predict complexity of mitral valve repair?. Eur J Cardiothorac Surg 41 (2012), 518–524.
28. Lang, R.M., Tsang, W., Weinert, L., et al. Valvular heart disease. The value of 3-dimensional echocardiography. J Am Coll Cardiol 58 (2011), 1933–1944.
29. Lang, R.M., Badano, L.P., Mor-Avi, V., et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 28 (2015), 1–39.e14.
30. Levine, R.A., Schwammenthal, E., Ischemic mitral regurgitation on the threshold of a solution: from paradoxes to unifying concepts. Circulation 112 (2005), 745–758.
31. He, S., Fontaine, A.A., Schwammenthal, E., et al. Integrated mechanism for functional mitral regurgitation: leaflet restriction versus coapting force: in vitro studies. Circulation 96 (1997), 1826–1834.
32. Otsuji, Y., Handschumacher, M.D., Schwammenthal, E., et al. Insights from three-dimensional echocardiography into the mechanism of functional mitral regurgitation: direct in vivo demonstration of altered leaflet tethering geometry. Circulation 96 (1997), 1999–2008.
33. Kwan, J., Shiota, T., Agler, D.A., et al. Geometric differences of the mitral apparatus between ischemic and dilated cardiomyopathy with significant mitral regurgitation: real-time three-dimensional echocardiography study. Circulation 107 (2003), 1135–1140.
34. Golba, K., Mokrzycki, K., Drozdz, J., et al. Mechanisms of functional mitral regurgitation in ischemic cardiomyopathy determined by transesophageal echocardiography (from the Surgical Treatment for Ischemic Heart Failure Trial). Am J Cardiol 112 (2013), 1812–1818.
35. Otsuji, Y., Gilon, D., Jiang, L., et al. Restricted diastolic opening of the mitral leaflets in patients with left ventricular dysfunction: evidence for increased valve tethering. J Am Coll Cardiol 32 (1998), 398–404.
36. Gertz, Z.M., Raina, A., Saghy, L., et al. Evidence of atrial functional mitral regurgitation due to atrial fibrillation: reversal with arrhythmia control. J Am Coll Cardiol 58 (2011), 1474–1481.
37. Carpentier, A., Cardiac valve surgery—the “French correction.”. J Thorac Cardiovasc Surg 86 (1983), 323–337.
38. Suri, R.M., Vanoverschelde, J.L., Grigioni, F., et al. Association between early surgical intervention vs watchful waiting and outcomes for mitral regurgitation due to flail mitral valve leaflets. JAMA 310 (2013), 609–616.
39. Thomas, J.D., Liu, C.M., Flachskampf, F.A., et al. Quantification of jet flow by momentum analysis. An in vitro color Doppler flow study. Circulation 81 (1990), 247–259.
40. Uretsky, S., Gillam, L., Lang, R., et al. Discordance between echocardiography and MRI in the assessment of mitral regurgitation severity: a prospective multicenter trial. J Am Coll Cardiol 65 (2015), 1078–1088.
41. Singh, J.P., Evans, J.C., Levy, D., et al. Prevalence and clinical determinants of mitral, tricuspid, and aortic regurgitation (the Framingham Heart Study). Am J Cardiol 83 (1999), 897–902.
42. Chen, C.G., Thomas, J.D., Anconina, J., et al. Impact of impinging wall jet on color Doppler quantification of mitral regurgitation. Circulation 84 (1991), 712–720.
43. Sahn, D.J., Instrumentation and physical factors related to visualization of stenotic and regurgitant jets by Doppler color flow mapping. J Am Coll Cardiol 12 (1988), 1354–1365.
44. Lancellotti, P., Moura, L., Pierard, L.A., et al. European Association of Echocardiography recommendations for the assessment of valvular regurgitation. Part 2: mitral and tricuspid regurgitation (native valve disease). Eur J Echocardiogr 11 (2010), 307–332.
45. Topilsky, Y., Michelena, H., Bichara, V., et al. Mitral valve prolapse with mid-late systolic mitral regurgitation: pitfalls of evaluation and clinical outcome compared with holosystolic regurgitation. Circulation 125 (2012), 1643–1651.
46. Altiok, E., Hamada, S., van Hall, S., et al. Comparison of direct planimetry of mitral valve regurgitation orifice area by three-dimensional transesophageal echocardiography to effective regurgitant orifice area obtained by proximal flow convergence method and vena contracta area determined by color Doppler echocardiography. Am J Cardiol 107 (2011), 452–458.
47. Kahlert, P., Plicht, B., Schenk, I.M., et al. Direct assessment of size and shape of noncircular vena contracta area in functional versus organic mitral regurgitation using real-time three-dimensional echocardiography. J Am Soc Echocardiogr 21 (2008), 912–921.
48. Matsumura, Y., Fukuda, S., Tran, H., et al. Geometry of the proximal isovelocity surface area in mitral regurgitation by 3-dimensional color Doppler echocardiography: difference between functional mitral regurgitation and prolapse regurgitation. Am Heart J 155 (2008), 231–238.
49. Iwakura, K., Ito, H., Kawano, S., et al. Comparison of orifice area by transthoracic three-dimensional Doppler echocardiography versus proximal isovelocity surface area (PISA) method for assessment of mitral regurgitation. Am J Cardiol 97 (2006), 1630–1637.
50. Little, S.H., Pirat, B., Kumar, R., et al. Three-dimensional color Doppler echocardiography for direct measurement of vena contracta area in mitral regurgitation: in vitro validation and clinical experience. J Am Coll Cardiol Img 1 (2008), 695–704.
51. Yosefy, C., Hung, J., Chua, S., et al. Direct measurement of vena contracta area by real-time 3-dimensional echocardiography for assessing severity of mitral regurgitation. Am J Cardiol 104 (2009), 978–983.
52. Marsan, N.A., Westenberg, J.J., Ypenburg, C., et al. Quantification of functional mitral regurgitation by real-time 3D echocardiography: comparison with 3D velocity-encoded cardiac magnetic resonance. J Am Coll Cardiol Img 2 (2009), 1245–1252.
53. Shanks, M., Siebelink, H.M., Delgado, V., et al. Quantitative assessment of mitral regurgitation: comparison between three-dimensional transesophageal echocardiography and magnetic resonance imaging. Circ Cardiovasc Imaging 3 (2010), 694–700.
54. Zeng, X., Levine, R.A., Hua, L., et al. Diagnostic value of vena contracta area in the quantification of mitral regurgitation severity by color Doppler 3D echocardiography. Circ Cardiovasc Imaging 4 (2011), 506–513.
55. Matsumura, Y., Saracino, G., Sugioka, K., et al. Determination of regurgitant orifice area with the use of a new three-dimensional flow convergence geometric assumption in functional mitral regurgitation. J Am Soc Echocardiogr 21 (2008), 1251–1256.
56. Yoran, C., Yellin, E.L., Becker, R.M., et al. Dynamic aspects of acute mitral regurgitation: effects of ventricular volume, pressure and contractility on the effective regurgitant orifice area. Circulation 60 (1979), 170–176.
57. Hung, J., Otsuji, Y., Handschumacher, M.D., et al. Mechanism of dynamic regurgitant orifice area variation in functional mitral regurgitation: physiologic insights from the proximal flow convergence technique. J Am Coll Cardiol 33 (1999), 538–545.
58. Buck, T., Plicht, B., Kahlert, P., et al. Effect of dynamic flow rate and orifice area on mitral regurgitant stroke volume quantification using the proximal isovelocity surface area method. J Am Coll Cardiol 52 (2008), 767–778.
59. Fujita, N., Chazouilleres, A.F., Hartiala, J.J., et al. Quantification of mitral regurgitation by velocity-encoded cine nuclear magnetic resonance imaging. J Am Coll Cardiol 23 (1994), 951–958.
60. Hundley, W.G., Li, H.F., Willard, J.E., et al. Magnetic resonance imaging assessment of the severity of mitral regurgitation. Comparison with invasive techniques. Circulation 92 (1995), 1151–1158.
61. Kizilbash, A.M., Hundley, W.G., Willett, D.L., et al. Comparison of quantitative Doppler with magnetic resonance imaging for assessment of the severity of mitral regurgitation. Am J Cardiol 81 (1998), 792–795.
62. Kon, M.W., Myerson, S.G., Moat, N.E., et al. Quantification of regurgitant fraction in mitral regurgitation by cardiovascular magnetic resonance: comparison of techniques. J Heart Valve Dis 13 (2004), 600–607.
63. Maceira, A.M., Prasad, S.K., Khan, M., et al. Normalized left ventricular systolic and diastolic function by steady state free precession cardiovascular magnetic resonance. J Cardiovasc Magn Reson 8 (2006), 417–426.
64. Kizilbash, A.M., Willett, D.L., Brickner, M.E., et al. Effects of afterload reduction on vena contracta width in mitral regurgitation. J Am Coll Cardiol 32 (1998), 427–431.
65. Panidis, I.P., Ross, J., Munley, B., et al. Diastolic mitral regurgitation in patients with atrioventricular conduction abnormalities: a common finding by Doppler echocardiography. J Am Coll Cardiol 7 (1986), 768–774.
66. Grayburn, P.A., Carabello, B., Hung, J., et al. Defining “severe” secondary mitral regurgitation: emphasizing an integrated approach. J Am Coll Cardiol 64 (2014), 2792–2801.
67. Enriquez-Sarano, M., Tajik, A.J., Schaff, H.V., et al. Echocardiographic prediction of survival after surgical correction of organic mitral regurgitation. Circulation 90 (1994), 830–837.
68. Ling, L.H., Enriquez-Sarano, M., Seward, J.B., et al. Clinical outcome of mitral regurgitation due to flail leaflet. N Engl J Med 335 (1996), 1417–1423.
69. Le Tourneau, T., Messika-Zeitoun, D., Russo, A., et al. Impact of left atrial volume on clinical outcome in organic mitral regurgitation. J Am Coll Cardiol 56 (2010), 570–578.
70. Rusinaru, D., Tribouilloy, C., Grigioni, F., et al. Left atrial size is a potent predictor of mortality in mitral regurgitation due to flail leaflets: results from a large international multicenter study. Circ Cardiovasc Imaging 4 (2011), 473–481.
71. Lancellotti, P., Garbi, M., Malignant mitral valve prolapse: substrates to ventricular remodeling and arrhythmias. Circ Cardiovasc Imaging, 9, 2016, e005248.
72. Goldstein, D., Moskowitz, A.J., Gelijns, A.C., et al. Two-year outcomes of surgical treatment of severe ischemic mitral regurgitation. N Engl J Med 374 (2016), 344–353.
73. Nishimura, R.A., Vahanian, A., Eleid, M.F., et al. Mitral valve disease—current management and future challenges. Lancet 387 (2016), 1324–1334.
74. Vassileva, C.M., Mishkel, G., McNeely, C., et al. Long-term survival of patients undergoing mitral valve repair and replacement: a longitudinal analysis of Medicare fee-for-service beneficiaries. Circulation 127 (2013), 1870–1876.
75. Badhwar, V., Peterson, E.D., Jacobs, J.P., et al. Longitudinal outcome of isolated mitral repair in older patients: results from 14,604 procedures performed from 1991 to 2007. Ann Thorac Surg 94 (2012), 1870–1877 discussion 7–9.
76. Chan, K.M., Punjabi, P.P., Flather, M., et al. Coronary artery bypass surgery with or without mitral valve annuloplasty in moderate functional ischemic mitral regurgitation: final results of the Randomized Ischemic Mitral Evaluation (RIME) trial. Circulation 126 (2012), 2502–2510.
77. Fattouch, K., Guccione, F., Sampognaro, R., et al. POINT: efficacy of adding mitral valve restrictive annuloplasty to coronary artery bypass grafting in patients with moderate ischemic mitral valve regurgitation: a randomized trial. J Thorac Cardiovasc Surg 138 (2009), 278–285.
78. Michler, R.E., Smith, P.K., Parides, M.K., et al. Two-year outcomes of surgical treatment of moderate ischemic mitral regurgitation. N Engl J Med 374 (2016), 1932–1941.
79. Badhwar, V., Smith, A.J., Cavalcante, J.L., A pathoanatomic approach to the management of mitral regurgitation. Trends Cardiovasc Med 26 (2016), 126–134.
80. Adams, D.H., Rosenhek, R., Falk, V., Degenerative mitral valve regurgitation: best practice revolution. Eur Heart J 31 (2010), 1958–1966.
81. Anyanwu, A.C., Adams, D.H., Why do mitral valve repairs fail?. J Am Soc Echocardiogr 22 (2009), 1265–1268.
82. Murashita, T., Okada, Y., Fujiwara, H., et al. Mechanism of and risk factors for reoperation after mitral valve repair for degenerative mitral regurgitation. Circ J 77 (2013), 2050–2055.
83. Suri, R.M., Clavel, M.A., Schaff, H.V., et al. Effect of recurrent mitral regurgitation following degenerative mitral valve repair: long-term analysis of competing outcomes. J Am Coll Cardiol 67 (2016), 488–498.
84. Bolling, S.F., Li, S., O'Brien, S.M., et al. Predictors of mitral valve repair: clinical and surgeon factors. Ann Thorac Surg 90 (2010), 1904–1911 discussion 12.
85. Badhwar, V., Rankin, J.S., He, X., et al. The Society of Thoracic Surgeons mitral repair/replacement composite score: a report of the Society of Thoracic Surgeons Quality Measurement Task Force. Ann Thorac Surg 101 (2016), 2265–2271.
86. Badhwar, V., Thourani, V.H., Ailawadi, G., et al. Transcatheter mitral valve therapy: the event horizon. J Thorac Cardiovasc Surg 152 (2016), 330–336.
87. O'Brien, S.M., Shahian, D.M., Filardo, G., et al. The Society of Thoracic Surgeons 2008 cardiac surgery risk models: part 2—isolated valve surgery. Ann Thorac Surg 88 (2009), S23–S42.
88. Feldman, T., Kar, S., Elmariah, S., et al. Randomized comparison of percutaneous repair and surgery for mitral regurgitation: 5-year results of EVEREST II. J Am Coll Cardiol 66 (2015), 2844–2854.
89. Lim, D.S., Reynolds, M.R., Feldman, T., et al. Improved functional status and quality of life in prohibitive surgical risk patients with degenerative mitral regurgitation after transcatheter mitral valve repair. J Am Coll Cardiol 64 (2014), 182–192.
90. Maisano, F., Franzen, O., Baldus, S., et al. Percutaneous mitral valve interventions in the real world: early and 1-year results from the ACCESS-EU, a prospective, multicenter, nonrandomized post-approval study of the MitraClip therapy in Europe. J Am Coll Cardiol 62 (2013), 1052–1061.
91. Maisano, F., Alfieri, O., Banai, S., et al. The future of transcatheter mitral valve interventions: competitive or complementary role of repair vs. replacement?. Eur Heart J 36 (2015), 1651–1659.
92. Muller, D.W., Farivar, R.S., Jansz, P., et al. Transcatheter mitral valve replacement for patients with symptomatic mitral regurgitation: a global feasibility trial. J Am Coll Cardiol 69 (2017), 381–391.
93. Alfieri, O., Maisano, F., De Bonis, M., et al. The double-orifice technique in mitral valve repair: a simple solution for complex problems. J Thorac Cardiovasc Surg 122 (2001), 674–681.
94. Mauri, L., Foster, E., Glower, D.D., et al. 4-year results of a randomized controlled trial of percutaneous repair versus surgery for mitral regurgitation. J Am Coll Cardiol 62 (2013), 317–328.
95. Pleger, S.T., Schulz-Schonhagen, M., Geis, N., et al. One year clinical efficacy and reverse cardiac remodelling in patients with severe mitral regurgitation and reduced ejection fraction after MitraClip implantation. Eur J Heart Fail 15 (2013), 919–927.
96. Hahn, R.T., Transcathether valve replacement and valve repair: review of procedures and intraprocedural echocardiographic imaging. Circ Res 119 (2016), 341–356.
97. Grover, F.L., Vemulapalli, S., Carroll, J.D., et al. 2016 annual report of the Society of Thoracic Surgeons/American College of Cardiology Transcatheter Valve Therapy Registry. J Am Coll Cardiol 69 (2017), 1215–1230.